Center for Speech & Language Recovery
Clinical Trials

You are here

rTMS or tDCS and Speech Therapy in Sub-Acute Stroke

CLINICAL TRIAL: 
Complete
September 1, 2015 to September 1, 2017
Trial Identifier: 
NCT02020421
Published Clinical Trial: 
clinicaltrials.gov

The goal of this multinational clinical trial is to determine whether navigation guided 1 Hz rTMS (or cathodal tDCS) targeting the non-lesioned hemisphere Broca’s area homologue in patients with post-stroke aphasia, has a beneficial effect when combined with inpatient speech therapy.

Eligibility

Age Range: 
50 Years to 85 Years
Gender: 
Both (Male and Female)
Healthy Volunteers: 
No
Inclusion Criteria: 
  • Ischemic stroke in the left MCA territory
  • Between 5 and 30 days post stroke
  • Right-handedness
  • English, French or German as language of daily use
  • Score below the lower limit of the norm on at least one of the primary outcome measures
Exclusion Criteria: 
  • Prior symptomatic ischemic or hemorrhagic stroke
  • Severe comprehension deficit that may compromise informed consent or understanding of instructions
  • Contraindications to MRI and/or TMS/tDCS
  • Neurodegenerative or psychiatric disease
  • Epilepsy or EEG-documented epileptic discharges
  • Chronic renal or liver failure
  • Life-threatening diseases
  • Auditory or visual deficits that cannot be corrected and might impair testing

Sponsor

Northstar Trial

Inquire About Clinical Trials

If you would like more information regarding the clinical trials conducted at Burke Neurological Institute or to express your interest in participating, please fill out and submit this form.

Your Information

Name & Address

A Few Questions

Clinical Trials

(Check all that are of interest)
(Title of clinical trial currently viewing)

Your Message

Study Locations

Burke Medical Research Institute
785 Mamaroneck Avenue
White Plains, NY 10573

Associated